by Jason Heaviland | Aug 4, 2026 | Uncategorized
Pregnancy Is More Than Genetics Pregnancy is often discussed through the lens of hormones, genetics and fetal development. But there is another layer influencing maternal and fetal health that researchers are increasingly paying attention to: environmental chemical...
by Jason Heaviland | Jun 15, 2026 | Uncategorized
Why Cell Therapy Target Selection Is So Difficult Antibody-drug conjugates (ADCs) and CAR-T therapies have reshaped modern oncology, but their success still depends on one deceptively simple question: are we targeting the right protein? In practice, answering this is...
by Jason Heaviland | Jun 2, 2026 | Uncategorized
Transcript featuring Gary Patti (Panome Bio) and Dipender Gill (Sequoia Genetics) DIPENDER So Gary, great to get a chance to talk again. I know we’ve had numerous really stimulating conversations about proteomics, genetics, the intersection of science, and how...
by Jason Heaviland | May 21, 2026 | Uncategorized
Drug development is expensive, slow, and highly unpredictable. Despite major advances in genomics and precision medicine, nearly 90% of drug candidates still fail (Doi: 10.1016/j.apsb.2022.02.002) during clinical development, often because the selected target was not...
by Jason Heaviland | Apr 28, 2026 | Uncategorized
What if untargeted metabolomics delivered on its promise? For years, untargeted metabolomics has been one of the most compelling approaches in biology: measure broadly, capture molecular diversity and improve biological interpretation and understanding. In practice,...
